FILE PHOTO: Ehud Barak, chairman of InterCure, a holding company of small medical firms, that bought medical cannabis developer Canndoc, speaks during an interview with Reuters in Tel Aviv, Israel January 29, 2019. REUTERS/Ronen Zvulun